• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Pediatrics Medicine Market Size, Status and Forecast 2020-2026

report cover
  • 15 June 2020
  • Pharmaceuticals
  • 134 Pages
  • Report Code: 24LS-7575
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Pediatrics Medicine -MARKET ADVISORY SERVICES

This report focuses on the global Pediatrics Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pediatrics Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.


The key players covered in this study

  • GSK
  • Novartis
  • Pfizer
  • Sanofi
  • Abbott
  • Bristol-Myers Squibb
  • Cipla
  • Eisai Pharmaceuticals
  • Eli Lilly
  • F. Hoffman-La Roche
  • Glenmark
  • Helsinn Healthcare
  • Heron Therapeutics
  • Ipca Laboratories
  • Lupin Pharmaceuticals
  • Merck Sharp & Dohme
  • RedHill
  • Sun Pharmaceutical Industries
  • Takeda Pharmaceutical


Market segment by Type, the product can be split into

  • Enteral
  • Parenteral

Market segment by Application, split into

  • Respiratory diseases
  • Infectious diseases
  • Gastrointestinal diseases
  • CNS diseases
  • Oncological diseases
  • CVDs
  • Others


Market segment by Regions/Countries, this report covers

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America


The study objectives of this report are:

  • To analyze global Pediatrics Medicine status, future forecast, growth opportunity, key market and key players.
  • To present the Pediatrics Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.


In this study, the years considered to estimate the market size of Pediatrics Medicine are as follows:

  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pediatrics Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Pediatrics Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Enteral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Pediatrics Medicine Market Share by Application: 2020 VS 2026
1.5.2 Respiratory diseases
1.5.3 Infectious diseases
1.5.4 Gastrointestinal diseases
1.5.5 CNS diseases
1.5.6 Oncological diseases
1.5.7 CVDs
1.5.8 Others
1.6 Coronavirus Disease 2019 (Covid-19): Pediatrics Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Pediatrics Medicine Industry
1.6.1.1 Pediatrics Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pediatrics Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pediatrics Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Pediatrics Medicine Market Perspective (2015-2026)
2.2 Pediatrics Medicine Growth Trends by Regions
2.2.1 Pediatrics Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pediatrics Medicine Historic Market Share by Regions (2015-2020)
2.2.3 Pediatrics Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pediatrics Medicine Market Growth Strategy
2.3.6 Primary Interviews with Key Pediatrics Medicine Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Pediatrics Medicine Players by Market Size
3.1.1 Global Top Pediatrics Medicine Players by Revenue (2015-2020)
3.1.2 Global Pediatrics Medicine Revenue Market Share by Players (2015-2020)
3.1.3 Global Pediatrics Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pediatrics Medicine Market Concentration Ratio
3.2.1 Global Pediatrics Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pediatrics Medicine Revenue in 2019
3.3 Pediatrics Medicine Key Players Head office and Area Served
3.4 Key Players Pediatrics Medicine Product Solution and Service
3.5 Date of Enter into Pediatrics Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Pediatrics Medicine Historic Market Size by Type (2015-2020)
4.2 Global Pediatrics Medicine Forecasted Market Size by Type (2021-2026)

5 Pediatrics Medicine Breakdown Data by Application (2015-2026)
5.1 Global Pediatrics Medicine Market Size by Application (2015-2020)
5.2 Global Pediatrics Medicine Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Pediatrics Medicine Market Size (2015-2020)
6.2 Pediatrics Medicine Key Players in North America (2019-2020)
6.3 North America Pediatrics Medicine Market Size by Type (2015-2020)
6.4 North America Pediatrics Medicine Market Size by Application (2015-2020)

7 Europe
7.1 Europe Pediatrics Medicine Market Size (2015-2020)
7.2 Pediatrics Medicine Key Players in Europe (2019-2020)
7.3 Europe Pediatrics Medicine Market Size by Type (2015-2020)
7.4 Europe Pediatrics Medicine Market Size by Application (2015-2020)

8 China
8.1 China Pediatrics Medicine Market Size (2015-2020)
8.2 Pediatrics Medicine Key Players in China (2019-2020)
8.3 China Pediatrics Medicine Market Size by Type (2015-2020)
8.4 China Pediatrics Medicine Market Size by Application (2015-2020)

9 Japan
9.1 Japan Pediatrics Medicine Market Size (2015-2020)
9.2 Pediatrics Medicine Key Players in Japan (2019-2020)
9.3 Japan Pediatrics Medicine Market Size by Type (2015-2020)
9.4 Japan Pediatrics Medicine Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Pediatrics Medicine Market Size (2015-2020)
10.2 Pediatrics Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pediatrics Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Pediatrics Medicine Market Size by Application (2015-2020)

11 India
11.1 India Pediatrics Medicine Market Size (2015-2020)
11.2 Pediatrics Medicine Key Players in India (2019-2020)
11.3 India Pediatrics Medicine Market Size by Type (2015-2020)
11.4 India Pediatrics Medicine Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Pediatrics Medicine Market Size (2015-2020)
12.2 Pediatrics Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Pediatrics Medicine Market Size by Type (2015-2020)
12.4 Central & South America Pediatrics Medicine Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 GSK
13.1.1 GSK Company Details
13.1.2 GSK Business Overview and Its Total Revenue
13.1.3 GSK Pediatrics Medicine Introduction
13.1.4 GSK Revenue in Pediatrics Medicine Business (2015-2020))
13.1.5 GSK Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis Pediatrics Medicine Introduction
13.2.4 Novartis Revenue in Pediatrics Medicine Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview and Its Total Revenue
13.3.3 Pfizer Pediatrics Medicine Introduction
13.3.4 Pfizer Revenue in Pediatrics Medicine Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Sanofi
13.4.1 Sanofi Company Details
13.4.2 Sanofi Business Overview and Its Total Revenue
13.4.3 Sanofi Pediatrics Medicine Introduction
13.4.4 Sanofi Revenue in Pediatrics Medicine Business (2015-2020)
13.4.5 Sanofi Recent Development
13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview and Its Total Revenue
13.5.3 Abbott Pediatrics Medicine Introduction
13.5.4 Abbott Revenue in Pediatrics Medicine Business (2015-2020)
13.5.5 Abbott Recent Development
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.6.3 Bristol-Myers Squibb Pediatrics Medicine Introduction
13.6.4 Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development
13.7 Cipla
13.7.1 Cipla Company Details
13.7.2 Cipla Business Overview and Its Total Revenue
13.7.3 Cipla Pediatrics Medicine Introduction
13.7.4 Cipla Revenue in Pediatrics Medicine Business (2015-2020)
13.7.5 Cipla Recent Development
13.8 Eisai Pharmaceuticals
13.8.1 Eisai Pharmaceuticals Company Details
13.8.2 Eisai Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Eisai Pharmaceuticals Pediatrics Medicine Introduction
13.8.4 Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020)
13.8.5 Eisai Pharmaceuticals Recent Development
13.9 Eli Lilly
13.9.1 Eli Lilly Company Details
13.9.2 Eli Lilly Business Overview and Its Total Revenue
13.9.3 Eli Lilly Pediatrics Medicine Introduction
13.9.4 Eli Lilly Revenue in Pediatrics Medicine Business (2015-2020)
13.9.5 Eli Lilly Recent Development
13.10 F. Hoffman-La Roche
13.10.1 F. Hoffman-La Roche Company Details
13.10.2 F. Hoffman-La Roche Business Overview and Its Total Revenue
13.10.3 F. Hoffman-La Roche Pediatrics Medicine Introduction
13.10.4 F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2015-2020)
13.10.5 F. Hoffman-La Roche Recent Development
13.11 Glenmark
10.11.1 Glenmark Company Details
10.11.2 Glenmark Business Overview and Its Total Revenue
10.11.3 Glenmark Pediatrics Medicine Introduction
10.11.4 Glenmark Revenue in Pediatrics Medicine Business (2015-2020)
10.11.5 Glenmark Recent Development
13.12 Helsinn Healthcare
10.12.1 Helsinn Healthcare Company Details
10.12.2 Helsinn Healthcare Business Overview and Its Total Revenue
10.12.3 Helsinn Healthcare Pediatrics Medicine Introduction
10.12.4 Helsinn Healthcare Revenue in Pediatrics Medicine Business (2015-2020)
10.12.5 Helsinn Healthcare Recent Development
13.13 Heron Therapeutics
10.13.1 Heron Therapeutics Company Details
10.13.2 Heron Therapeutics Business Overview and Its Total Revenue
10.13.3 Heron Therapeutics Pediatrics Medicine Introduction
10.13.4 Heron Therapeutics Revenue in Pediatrics Medicine Business (2015-2020)
10.13.5 Heron Therapeutics Recent Development
13.14 Ipca Laboratories
10.14.1 Ipca Laboratories Company Details
10.14.2 Ipca Laboratories Business Overview and Its Total Revenue
10.14.3 Ipca Laboratories Pediatrics Medicine Introduction
10.14.4 Ipca Laboratories Revenue in Pediatrics Medicine Business (2015-2020)
10.14.5 Ipca Laboratories Recent Development
13.15 Lupin Pharmaceuticals
10.15.1 Lupin Pharmaceuticals Company Details
10.15.2 Lupin Pharmaceuticals Business Overview and Its Total Revenue
10.15.3 Lupin Pharmaceuticals Pediatrics Medicine Introduction
10.15.4 Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020)
10.15.5 Lupin Pharmaceuticals Recent Development
13.16 Merck Sharp & Dohme
10.16.1 Merck Sharp & Dohme Company Details
10.16.2 Merck Sharp & Dohme Business Overview and Its Total Revenue
10.16.3 Merck Sharp & Dohme Pediatrics Medicine Introduction
10.16.4 Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2015-2020)
10.16.5 Merck Sharp & Dohme Recent Development
13.17 RedHill
10.17.1 RedHill Company Details
10.17.2 RedHill Business Overview and Its Total Revenue
10.17.3 RedHill Pediatrics Medicine Introduction
10.17.4 RedHill Revenue in Pediatrics Medicine Business (2015-2020)
10.17.5 RedHill Recent Development
13.18 Sun Pharmaceutical Industries
10.18.1 Sun Pharmaceutical Industries Company Details
10.18.2 Sun Pharmaceutical Industries Business Overview and Its Total Revenue
10.18.3 Sun Pharmaceutical Industries Pediatrics Medicine Introduction
10.18.4 Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2015-2020)
10.18.5 Sun Pharmaceutical Industries Recent Development
13.19 Takeda Pharmaceutical
10.19.1 Takeda Pharmaceutical Company Details
10.19.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
10.19.3 Takeda Pharmaceutical Pediatrics Medicine Introduction
10.19.4 Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2015-2020)
10.19.5 Takeda Pharmaceutical Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Pediatrics Medicine Key Market Segments

Table 2. Key Players Covered: Ranking by Pediatrics Medicine Revenue

Table 3. Ranking of Global Top Pediatrics Medicine Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Pediatrics Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Enteral

Table 6. Key Players of Parenteral

Table 7. COVID-19 Impact Global Market: (Four Pediatrics Medicine Market Size Forecast Scenarios)

Table 8. Opportunities and Trends for Pediatrics Medicine Players in the COVID-19 Landscape

Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 10. Key Regions/Countries Measures against Covid-19 Impact

Table 11. Proposal for Pediatrics Medicine Players to Combat Covid-19 Impact

Table 12. Global Pediatrics Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 13. Global Pediatrics Medicine Market Size by Regions (US$ Million): 2020 VS 2026

Table 14. Global Pediatrics Medicine Market Size by Regions (2015-2020) (US$ Million)

Table 15. Global Pediatrics Medicine Market Share by Regions (2015-2020)

Table 16. Global Pediatrics Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 17. Global Pediatrics Medicine Market Share by Regions (2021-2026)

Table 18. Market Top Trends

Table 19. Key Drivers: Impact Analysis

Table 20. Key Challenges

Table 21. Pediatrics Medicine Market Growth Strategy

Table 22. Main Points Interviewed from Key Pediatrics Medicine Players

Table 23. Global Pediatrics Medicine Revenue by Players (2015-2020) (Million US$)

Table 24. Global Pediatrics Medicine Market Share by Players (2015-2020)

Table 25. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatrics Medicine as of 2019)

Table 26. Global Pediatrics Medicine by Players Market Concentration Ratio (CR5 and HHI)

Table 27. Key Players Headquarters and Area Served

Table 28. Key Players Pediatrics Medicine Product Solution and Service

Table 29. Date of Enter into Pediatrics Medicine Market

Table 30. Mergers & Acquisitions, Expansion Plans

Table 31. Global Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)

Table 32. Global Pediatrics Medicine Market Size Share by Type (2015-2020)

Table 33. Global Pediatrics Medicine Revenue Market Share by Type (2021-2026)

Table 34. Global Pediatrics Medicine Market Size Share by Application (2015-2020)

Table 35. Global Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)

Table 36. Global Pediatrics Medicine Market Size Share by Application (2021-2026)

Table 37. North America Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)

Table 38. North America Key Players Pediatrics Medicine Market Share (2019-2020)

Table 39. North America Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)

Table 40. North America Pediatrics Medicine Market Share by Type (2015-2020)

Table 41. North America Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)

Table 42. North America Pediatrics Medicine Market Share by Application (2015-2020)

Table 43. Europe Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)

Table 44. Europe Key Players Pediatrics Medicine Market Share (2019-2020)

Table 45. Europe Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)

Table 46. Europe Pediatrics Medicine Market Share by Type (2015-2020)

Table 47. Europe Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)

Table 48. Europe Pediatrics Medicine Market Share by Application (2015-2020)

Table 49. China Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)

Table 50. China Key Players Pediatrics Medicine Market Share (2019-2020)

Table 51. China Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)

Table 52. China Pediatrics Medicine Market Share by Type (2015-2020)

Table 53. China Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)

Table 54. China Pediatrics Medicine Market Share by Application (2015-2020)

Table 55. Japan Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)

Table 56. Japan Key Players Pediatrics Medicine Market Share (2019-2020)

Table 57. Japan Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)

Table 58. Japan Pediatrics Medicine Market Share by Type (2015-2020)

Table 59. Japan Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)

Table 60. Japan Pediatrics Medicine Market Share by Application (2015-2020)

Table 61. Southeast Asia Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)

Table 62. Southeast Asia Key Players Pediatrics Medicine Market Share (2019-2020)

Table 63. Southeast Asia Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)

Table 64. Southeast Asia Pediatrics Medicine Market Share by Type (2015-2020)

Table 65. Southeast Asia Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)

Table 66. Southeast Asia Pediatrics Medicine Market Share by Application (2015-2020)

Table 67. India Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)

Table 68. India Key Players Pediatrics Medicine Market Share (2019-2020)

Table 69. India Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)

Table 70. India Pediatrics Medicine Market Share by Type (2015-2020)

Table 71. India Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)

Table 72. India Pediatrics Medicine Market Share by Application (2015-2020)

Table 73. Central & South America Key Players Pediatrics Medicine Revenue (2019-2020) (Million US$)

Table 74. Central & South America Key Players Pediatrics Medicine Market Share (2019-2020)

Table 75. Central & South America Pediatrics Medicine Market Size by Type (2015-2020) (Million US$)

Table 76. Central & South America Pediatrics Medicine Market Share by Type (2015-2020)

Table 77. Central & South America Pediatrics Medicine Market Size by Application (2015-2020) (Million US$)

Table 78. Central & South America Pediatrics Medicine Market Share by Application (2015-2020)

Table 79. GSK Company Details

Table 80. GSK Business Overview

Table 81. GSK Product

Table 82. GSK Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 83. GSK Recent Development

Table 84. Novartis Company Details

Table 85. Novartis Business Overview

Table 86. Novartis Product

Table 87. Novartis Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 88. Novartis Recent Development

Table 89. Pfizer Company Details

Table 90. Pfizer Business Overview

Table 91. Pfizer Product

Table 92. Pfizer Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 93. Pfizer Recent Development

Table 94. Sanofi Company Details

Table 95. Sanofi Business Overview

Table 96. Sanofi Product

Table 97. Sanofi Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 98. Sanofi Recent Development

Table 99. Abbott Company Details

Table 100. Abbott Business Overview

Table 101. Abbott Product

Table 102. Abbott Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 103. Abbott Recent Development

Table 104. Bristol-Myers Squibb Company Details

Table 105. Bristol-Myers Squibb Business Overview

Table 106. Bristol-Myers Squibb Product

Table 107. Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 108. Bristol-Myers Squibb Recent Development

Table 109. Cipla Company Details

Table 110. Cipla Business Overview

Table 111. Cipla Product

Table 112. Cipla Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 113. Cipla Recent Development

Table 114. Eisai Pharmaceuticals Business Overview

Table 115. Eisai Pharmaceuticals Product

Table 116. Eisai Pharmaceuticals Company Details

Table 117. Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 118. Eisai Pharmaceuticals Recent Development

Table 119. Eli Lilly Company Details

Table 120. Eli Lilly Business Overview

Table 121. Eli Lilly Product

Table 122. Eli Lilly Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 123. Eli Lilly Recent Development

Table 124. F. Hoffman-La Roche Company Details

Table 125. F. Hoffman-La Roche Business Overview

Table 126. F. Hoffman-La Roche Product

Table 127. F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 128. F. Hoffman-La Roche Recent Development

Table 129. Glenmark Company Details

Table 130. Glenmark Business Overview

Table 131. Glenmark Product

Table 132. Glenmark Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 133. Glenmark Recent Development

Table 134. Helsinn Healthcare Company Details

Table 135. Helsinn Healthcare Business Overview

Table 136. Helsinn Healthcare Product

Table 137. Helsinn Healthcare Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 138. Helsinn Healthcare Recent Development

Table 139. Heron Therapeutics Company Details

Table 140. Heron Therapeutics Business Overview

Table 141. Heron Therapeutics Product

Table 142. Heron Therapeutics Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 143. Heron Therapeutics Recent Development

Table 144. Ipca Laboratories Company Details

Table 145. Ipca Laboratories Business Overview

Table 146. Ipca Laboratories Product

Table 147. Ipca Laboratories Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 148. Ipca Laboratories Recent Development

Table 149. Lupin Pharmaceuticals Company Details

Table 150. Lupin Pharmaceuticals Business Overview

Table 151. Lupin Pharmaceuticals Product

Table 152. Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 153. Lupin Pharmaceuticals Recent Development

Table 154. Merck Sharp & Dohme Company Details

Table 155. Merck Sharp & Dohme Business Overview

Table 156. Merck Sharp & Dohme Product

Table 157. Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 158. Merck Sharp & Dohme Recent Development

Table 159. RedHill Company Details

Table 160. RedHill Business Overview

Table 161. RedHill Product

Table 162. RedHill Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 163. RedHill Recent Development

Table 164. Sun Pharmaceutical Industries Company Details

Table 165. Sun Pharmaceutical Industries Business Overview

Table 166. Sun Pharmaceutical Industries Product

Table 167. Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 168. Sun Pharmaceutical Industries Recent Development

Table 169. Takeda Pharmaceutical Company Details

Table 170. Takeda Pharmaceutical Business Overview

Table 171. Takeda Pharmaceutical Product

Table 172. Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2015-2020) (Million US$)

Table 173. Takeda Pharmaceutical Recent Development

Table 174. Research Programs/Design for This Report

Table 175. Key Data Information from Secondary Sources

Table 176. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pediatrics Medicine Market Share by Type: 2020 VS 2026

Figure 2. Enteral Features

Figure 3. Parenteral Features

Figure 4. Global Pediatrics Medicine Market Share by Application: 2020 VS 2026

Figure 5. Respiratory diseases Case Studies

Figure 6. Infectious diseases Case Studies

Figure 7. Gastrointestinal diseases Case Studies

Figure 8. CNS diseases Case Studies

Figure 9. Oncological diseases Case Studies

Figure 10. CVDs Case Studies

Figure 11. Others Case Studies

Figure 12. Pediatrics Medicine Report Years Considered

Figure 13. Global Pediatrics Medicine Market Size YoY Growth 2015-2026 (US$ Million)

Figure 14. Global Pediatrics Medicine Market Share by Regions: 2020 VS 2026

Figure 15. Global Pediatrics Medicine Market Share by Regions (2021-2026)

Figure 16. Porter's Five Forces Analysis

Figure 17. Global Pediatrics Medicine Market Share by Players in 2019

Figure 18. Global Top Pediatrics Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatrics Medicine as of 2019

Figure 19. The Top 10 and 5 Players Market Share by Pediatrics Medicine Revenue in 2019

Figure 20. North America Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. Europe Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. China Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Japan Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. Southeast Asia Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)

Figure 25. India Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)

Figure 26. Central & South America Pediatrics Medicine Market Size YoY Growth (2015-2020) (Million US$)

Figure 27. GSK Total Revenue (US$ Million): 2019 Compared with 2018

Figure 28. GSK Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 29. Novartis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 30. Novartis Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 32. Pfizer Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 33. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 34. Sanofi Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 35. Abbott Total Revenue (US$ Million): 2019 Compared with 2018

Figure 36. Abbott Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 37. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018

Figure 38. Bristol-Myers Squibb Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 39. Cipla Total Revenue (US$ Million): 2019 Compared with 2018

Figure 40. Cipla Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 41. Eisai Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 42. Eisai Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 43. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018

Figure 44. Eli Lilly Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 45. F. Hoffman-La Roche Total Revenue (US$ Million): 2019 Compared with 2018

Figure 46. F. Hoffman-La Roche Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 47. Glenmark Total Revenue (US$ Million): 2019 Compared with 2018

Figure 48. Glenmark Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 49. Helsinn Healthcare Total Revenue (US$ Million): 2019 Compared with 2018

Figure 50. Helsinn Healthcare Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 51. Heron Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Heron Therapeutics Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 53. Ipca Laboratories Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. Ipca Laboratories Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 55. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 56. Lupin Pharmaceuticals Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 57. Merck Sharp & Dohme Total Revenue (US$ Million): 2019 Compared with 2018

Figure 58. Merck Sharp & Dohme Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 59. RedHill Total Revenue (US$ Million): 2019 Compared with 2018

Figure 60. RedHill Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 61. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018

Figure 62. Sun Pharmaceutical Industries Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 63. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018

Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Pediatrics Medicine Business (2015-2020)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

GSK

Novartis

Pfizer

Sanofi

Abbott

Bristol-Myers Squibb

Cipla

Eisai Pharmaceuticals

Eli Lilly

F. Hoffman-La Roche

Glenmark

Helsinn Healthcare

Heron Therapeutics

Ipca Laboratories

Lupin Pharmaceuticals

Merck Sharp & Dohme

RedHill

Sun Pharmaceutical Industries

Takeda Pharmaceutical

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3081

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase